DJIA 17,416.85 225.48 1.31%
NASDAQ 4,683.41 45.41 0.98%
S&P 500 2,021.25 19.09 0.95%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

31.50 -0.24 (-0.74%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SGEN $31.50 -0.74%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $31.76
Previous Close $31.74
Daily Range $31.07 - $31.96
52-Week Range $30.05 - $55.99
Market Cap $3.9B
P/E Ratio -61.03
Dividend (Yield) $0.00 (0.0%)
Volume 698,038
Average Daily Volume 1,369,800
Current FY EPS -$0.66





Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website:

News & Commentary Rss Feed

Why Seattle Genetics, Inc. Stock Dove 12% in December

Seattle Genetics' shares get hammered following impressive clinical data from its rivals at the American Society of Hematology's annual meeting. Find out whether this dip represents a buying opportunity or a red flag.

Earnings Peek: Market Seems Determined To Keep Seattle Genetics In The $30s

First Week of SGEN September 18th Options Trading

Commit To Buy Seattle Genetics At $25, Earn 8.5% Annualized Using Options

ALPS Puts Twist On Biotech Investing With Medical Breakthrough ETF

Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog

Seattle Genetics, Bristol-Myers to Study Adcetris-Opdivo - Analyst Blog

New Biotech ETF From ALPS

Bull of the Day: Incyte (INCY) - Bull of the Day

Seattle Genetics And Agios Pharmaceuticals: Opportunity Or Danger?

See More SGEN News...

SGEN's Top Competitors

SGEN $31.50 (-0.74%)
Current stock: SGEN
AMGN $156.37 (1.12%)
Current stock: AMGN
GILD $104.15 (1.66%)
Current stock: GILD
BIIB $353.25 (0.59%)
Current stock: BIIB